Osaka, Japan

Kazuaki Obata

USPTO Granted Patents = 3 


Average Co-Inventor Count = 4.6

ph-index = 3

Forward Citations = 20(Granted Patents)


Location History:

  • Toyonaka, JP (1994)
  • Osaka, JP (1999 - 2002)

Company Filing History:


Years Active: 1994-2002

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kazuaki Obata: Innovator in Nucleic Acid Technologies

Introduction

Kazuaki Obata is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of molecular biology, particularly in the area of nucleic acid technologies. With a total of 3 patents, his work has advanced the methods used for targeting and isolating nucleic acid sequences.

Latest Patents

One of his latest patents is titled "Methods for targeting, enriching, detecting and/or isolating target nucleic acid sequence using RecA-like recombinase." This innovative method involves targeting and enriching double-stranded nucleic acid sequences by incorporating heterologous probes into the reaction system. This process utilizes a reduced amount of homologous probes during homologous pairing and strand exchange, facilitated by a RecA-like recombinase. Another notable patent is an "In-situ hybridization method using RecA protein and RecA protein having." These patents reflect his expertise in enhancing nucleic acid detection techniques.

Career Highlights

Throughout his career, Kazuaki Obata has worked with notable companies such as Daikin Industries, Ltd. and Suntory Limited. His experience in these organizations has contributed to his development as an inventor and researcher in the field of molecular biology.

Collaborations

Kazuaki has collaborated with several talented individuals, including Koji Kigawa and Mikayo Yamanaka. These collaborations have likely enriched his research and innovation efforts.

Conclusion

Kazuaki Obata is a distinguished inventor whose work in nucleic acid technologies has led to significant advancements in the field. His patents and collaborations highlight his commitment to innovation and research excellence.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…